GSK Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	100,587	98,394	69,005	75,100	75,708	95,031
Market Cap Growth	28.55%	42.59%	-8.12%	-0.80%	-20.33%	19.87%
Enterprise Value	121,038	117,077	84,702	90,738	90,961	121,852
Last Close Price	50.04	49.04	33.82	37.03	35.12	44.10
PE Ratio	13.07	13.14	21.66	12.13	3.96	15.07
PS Ratio	2.32	2.24	1.75	1.95	2.13	2.85
PB Ratio	4.37	4.47	4.02	4.42	5.90	-
P/FCF Ratio	11.75	11.45	10.67	10.82	10.00	10.04
P/OCF Ratio	9.85	9.45	8.39	8.72	8.45	8.84
EV/Sales Ratio	2.80	2.67	2.15	2.35	2.56	3.65
EV/EBITDA Ratio	8.02	8.50	10.27	7.89	8.76	13.91
EV/EBIT Ratio	9.25	10.98	16.79	10.57	11.69	20.69
EV/FCF Ratio	14.13	13.62	13.09	13.07	12.01	12.87
Debt / Equity Ratio	0.80	0.92	1.12	1.19	1.69	0.96
Debt / EBITDA Ratio	2.38	1.73	2.59	1.99	2.45	3.73
Debt / FCF Ratio	2.99	2.77	3.30	3.30	3.35	3.45
Net Debt / Equity Ratio	0.88	0.87	0.96	0.96	1.24	-
Net Debt / EBITDA Ratio	1.95	1.40	1.99	1.42	1.53	3.06
Net Debt / FCF Ratio	2.45	2.24	2.54	2.35	2.09	2.83
Asset Turnover	0.53	0.54	0.53	0.51	0.42	0.31
Inventory Turnover	1.48	1.56	1.62	1.61	1.75	1.39
Quick Ratio	0.51	0.52	0.52	0.61	0.67	0.54
Current Ratio	0.79	0.82	0.78	0.88	0.91	0.79
Return on Equity (ROE)	38.09%	43.31%	22.80%	46.38%	31.31%	16.68%
Return on Assets (ROA)	11.04%	11.18%	5.76%	9.91%	8.08%	5.34%
Return on Invested Capital (ROIC)	21.63%	23.88%	13.17%	24.18%	17.47%	10.29%
Return on Capital Employed (ROCE)	19.98%	20.47%	10.62%	17.92%	13.87%	7.66%
Earnings Yield	7.65%	7.61%	4.62%	8.24%	25.23%	6.63%
FCF Yield	8.51%	8.74%	9.37%	9.24%	10.00%	9.96%
Dividend Yield	3.53%	3.47%	4.45%	3.81%	5.93%	6.13%
Payout Ratio	47.08%	44.86%	94.91%	45.60%	23.18%	91.20%
Buyback Yield / Dilution	1.13%	0.60%	-0.75%	-0.66%	-0.79%	-0.55%
Total Shareholder Return	4.66%	4.07%	3.69%	3.15%	5.14%	5.58%

SEC Filings: 10-K · 10-Q